Energy technology / Biotechnology / Design software
Reverion, Aptadir, Rayon — $175M for flexible energy, €40M for RNA therapies and €10M for design — Daily News September 29, 2026
01:51
•
29/09/2026
Listen on Spotify🇮🇹 Podcast in Italian
About this episode
Reverion closes a $175 million Series B, Aptadir a €40 million seed round, and Rayon a €10 million Series A.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
Main news
Startups mentioned
Reverion
A Munich TUM spin-off developing reversible solid-oxide fuel-cell power plants, with a stated 74.2% electrical efficiency.
Aptadir Therapeutics
A preclinical Milan biotech developing RNA inhibitors to reverse DNA hypermethylation and reactivate silenced genes.
Rayon
A Paris-based browser platform connecting drawings, specifications and real-time collaboration for interior design.
Listen to the episode
Listen on Spotify🇮🇹 Podcast in Italian